Fortune 500 Pharmaceutical Company Restructure Analysis and Divestiture Strategy (client confidential)

[distance]
Illustration of a new urban area

[list-ul type=”arrow”]

[li-row]Financial restructure and divestiture analysis of a biotechnology and R&D facility[/li-row]

[li-row]Asset and liability assessment, quantification, monetization, and mitigation analysis including environmental remediation and demolition liabilities[/li-row]

[li-row]Market feasibility study and highest and best use analysis and development of a campus master plan for mixed use retail, hospitality and office building use/reuse[/li-row]

[li-row]Identification and financial analysis of a range of divestiture/reuse options including self-development, sale “as is, where is”, mixed use residential/commercial, custodial care for future use

[/li-row][/list-ul]